Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04403919 · ClinicalTrials.gov registry record · NA

Knotless Suture in Revision Total Joint Arthroplasty

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
81
Enrollment target

NCT04403919 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 81 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04403919, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target

Study Summary

Barbed suture has been demonstrated to be safe in primary hip and knee surgery and retrospective data suggests barbed suture represents no increased complications in the revision setting. Barbed suture may represent a faster, more effective way to perform revision arthroplasty closures. There are no Level I studies comparing traditional and barbed suture closure. The purpose of this study is to assess the surgical complexities of closures using closure time without sacrificing cosmesis or wound complications between the traditional closure and barbed closure.

Interventions

  • DEVICE Conventional Closure: Knee
  • DEVICE Barbed suture closure: Knee
  • DEVICE Conventional Closure: Hip
  • DEVICE Barbed suture closure: Hip

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2020-09-01
Est. Completion 2023-06-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04403919

The ClinicalTrials.gov registry entry for NCT04403919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Conventional Closure: Knee is the first listed.

NCT04403919 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04403919 about?

NCT04403919 is a clinical study titled "Knotless Suture in Revision Total Joint Arthroplasty". Barbed suture has been demonstrated to be safe in primary hip and knee surgery and retrospective data suggests barbed suture represents no increased complications in the revision setting. Barbed suture may represent a faster, more effective way to perform revision arthroplasty closures. There are no...

What is the current status of trial NCT04403919?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2020-09-01. Estimated completion is 2023-06-01.

What interventions are being tested in trial NCT04403919?

The interventions under investigation include: Conventional Closure: Knee (DEVICE), Barbed suture closure: Knee (DEVICE), Conventional Closure: Hip (DEVICE), Barbed suture closure: Hip (DEVICE).

Who is sponsoring clinical trial NCT04403919?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.